BrentPeterForesterMD
Geriatrics • Belmont, MAMcLean Hospital - Chief, Division of Geriatric Psychiatry; Medical Director, Dementia Care and Behavioral & Mental Health, Population Health Management, Mass General Brigham Harvard Medical School - Associate Professor of Psychiatry
Dr. Forester is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
115 Mill St
Belmont, MA 02478Phone+1 617-855-3622
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Geriatric Psychiatry, 1996 - 1997
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1992 - 1996
Geisel School of Medicine at DartmouthClass of 1992
Certifications & Licensure
NH State Medical License 1996 - 2026
MA State Medical License 1994 - 2025- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Clinical Trials
- Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression Start of enrollment: 2018 May 29
Publications & Presentations
PubMed
- Potential impact of the COVID-19 pandemic on everyday preferences for persons with cognitive impairment.James M Wilkins, Joseph J Locascio, Teresa Gomez-Isla, Bradley T Hyman, Deborah Blacker
International Psychogeriatrics. 2024-12-01 - Collaborative Dementia Care During the New Therapeutic Era.Katherine L Possin, Jeffrey M Burns, Brent P Forester
JAMA Neurology. 2024-12-01 - Health of the Pandemic Dementia Paid Staff and Unpaid Caregiver Workforce in Congregate Care and Community Settings.Karen Donelan, Michael Vetter, Esteban Barreto, Sarah M Bannon, Inga Antonsdottir
The American Journal of Geriatric Psychiatry. 2024-10-22
Press Mentions
Cannabis Product May Help Ease Agitation of Alzheimer’sOctober 9th, 2024
Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s DiseaseOctober 2nd, 2024- Dronabinol Shows Promise in Reducing Agitation in Alzheimer's PatientsOctober 1st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
